Furthermore, IF results showed that APG treatment not only ameliorated the reduced distribution of NeuN and ALDH1A2 in ALS mouse tissues, but also significantly counteracted the exacerbating effects of sh-ALDH1A2 on ALS (Fig. 8B). The gene discussed is RBFOX3; the disease is amyotrophic lateral sclerosis.